Cargando…

Increased pathologic complete response are expected in HER2-positive and triple-negative locally advanced breast cancers

Detalles Bibliográficos
Autor principal: Altundag, Kadri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5424415/
https://www.ncbi.nlm.nih.gov/pubmed/28486984
http://dx.doi.org/10.1186/s40880-017-0208-5
_version_ 1783235131532640256
author Altundag, Kadri
author_facet Altundag, Kadri
author_sort Altundag, Kadri
collection PubMed
description
format Online
Article
Text
id pubmed-5424415
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-54244152017-05-11 Increased pathologic complete response are expected in HER2-positive and triple-negative locally advanced breast cancers Altundag, Kadri Chin J Cancer Correspondence BioMed Central 2017-05-10 /pmc/articles/PMC5424415/ /pubmed/28486984 http://dx.doi.org/10.1186/s40880-017-0208-5 Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Correspondence
Altundag, Kadri
Increased pathologic complete response are expected in HER2-positive and triple-negative locally advanced breast cancers
title Increased pathologic complete response are expected in HER2-positive and triple-negative locally advanced breast cancers
title_full Increased pathologic complete response are expected in HER2-positive and triple-negative locally advanced breast cancers
title_fullStr Increased pathologic complete response are expected in HER2-positive and triple-negative locally advanced breast cancers
title_full_unstemmed Increased pathologic complete response are expected in HER2-positive and triple-negative locally advanced breast cancers
title_short Increased pathologic complete response are expected in HER2-positive and triple-negative locally advanced breast cancers
title_sort increased pathologic complete response are expected in her2-positive and triple-negative locally advanced breast cancers
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5424415/
https://www.ncbi.nlm.nih.gov/pubmed/28486984
http://dx.doi.org/10.1186/s40880-017-0208-5
work_keys_str_mv AT altundagkadri increasedpathologiccompleteresponseareexpectedinher2positiveandtriplenegativelocallyadvancedbreastcancers